Company Profile

Astellas Pharma Inc (OTC: ALPMY)
4:59 PM UTC, 07/03/24
Last: $9.80 Change: -0.01 %Change: -0.15% Volume: 51,511
Detailed Quote
Open: $ 9.81   Volume: 51,511
High: $ 9.83   Yield(%) 3.72
Low: $ 9.78   P/E Ratio (ttm): 149.71
Dividend ($): 0.20   Market Cap ($): 17.64B
EPS ($) 0.06   Shares Out: 1.79B
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): -3.40
% Price Change (last 13 weeks): -9.56
% Price Change (last 26 weeks): -17.20
% Price Change (last 52 weeks): -33.74
% Price Change (year to date): -17.72
Management Effectiveness
Return on Equity (%): 1.08
Return on Assets (%): 0.56
Return on Invested Capital (%): 7.76
Profitability
Gross Profit Margin (%): 75.60
Net Profit Margin (%): 1.06
Operating Profit Margin (%): 11.10
Price & Volume
50-day Moving Average: $9.77
200-day Moving Average: $11.30
Avg. Daily Vol. (last 50 days): 343,387
Avg. Daily Vol. (last 200 days): 308,053
52-wk high: $15.90
52-wk low: $9.15
Bid: $n/a
Ask: $n/a
Company Information
Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products focus on therapeutic fields that include transplantation, immunology, infectious diseases, urology, oncology, neuroscience, diabetic complications, and metabolic diseases. The firm's global brands include Prograf, Vesicare, Protopic, Harnal, and Funguard. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.
Astellas Pharma Inc
2-5-1 Nihonbashi-Honcho Chuo-Ku
Tokyo TY 103-8411

Phone: 81.3.3244.3000
Fax: n/a
http://www.astellas.com
Per Share Data
Earnings (1year) ($): 0.06
Annual Dividend ($): 0.37
Current P/E Ratio (ttm): 149.71
Book Value ($): 5.88
Cash Flow ($): 0.67
Valuation Ratios
Price/Earnings (x): 149.71
Price/Sales (x): 1.74
Price/Book (x): 1.83
Price/Cash Flow (x): 15.41
Financial Strength
Quick Ratio (x): 0.74
Current Ratio (x): 0.93
LT Debt/Equity (x): 32.49
Total Debt/Equity (x): 63.02



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2020 Wall Street Horizon, Inc.